mrm-generics know amrn will receive injunction--so nothing for them to gain to schlep this out. Plus , they probably don't have the mechanism to manufacture pure epa at this moment.
Re: hurting amrn, the bottom line is: GENERICS AREN'T LOOKING TO PUNISH AMRN, rather they act in their (shareholders) best interest at all times.
Market Data 
Markets 
AI
